Home Drugs Clinical trials

Clinical trials

Dogs or mice? Our exclusive with Dr Steven Austad

If we're going to find robust solutions for aging, we may need more than mouse models — argues the University of Alabama at Birmingham's...

Biogen’s Alzheimer’s drug is back from the dead

From Biogen, the first drug to actually slow the decline of Alzheimer's disease, rather than just ameliorate the symptoms, is alive and seeking FDA...

Deep dive report: From mice to men

Mouse models used for research in aging therapies can only go so far in progressing human Longevity. Longevity.Technology: In this deep dive report we talk with experienced...

Dr Nir Barzilai: Creating a template for all aging trials

There are few voices in Longevity research as distinctive as Dr Nir Barzilai’s. Brimming with jokes and references, his sentences digress and then return...

ADVERT

ADVERT

Latest articles

Small rooms, big opportunities

Thoughts from the floor of the Investing in the Age of Longevity conference. There’s something I love about being in a small conference room discussing...

New xenotransplantation technology raises $100m

eGenesis race to deliver safe xenotransplantation, is this a welcome reset for xeno technology? The transplantation of animal organs to humans is still a relatively...

Gene editing: “fear and excitement in equal measure”

Top lawyer highlights concerns raised by expected growth in gene editing sector. Earlier this year, a major US financial analyst firm identified Longevity as one...

London addresses the 100 year life. Get ready!

Key summit: Increased global Longevity is a “problem of success”. Today, as part of Longevity Week London 2019, we attended the International Longevity Policy and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.